Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sentien Biotechnologies, Inc. logo — Restoring Balance to the Immune System

Sentien Biotechnologies, Inc.

Restoring Balance to the Immune System

Founded 2008 5 employees Series A Total: $15.13M Biotechnology, Health Care +1

General Information

Company Name Sentien Biotechnologies, Inc.
Founded Year 2008
Employees 5
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Sentien Biotechnologies, Inc.. To contact Sentien Biotechnologies, Inc., visit sentienbiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Sentien Biotechnologies, Inc.

Sentien Biotechnologies, Inc. is a biotechnology company with a mission to restore balance to the immune system by harnessing the power of cell therapy and innovative drug delivery systems. Founded in 2008, Sentien focuses on treating a wide range of acute inflammatory diseases. The company's lead product is designed to enable controlled and sustained delivery of mesenchymal stem cell (MSC) secreted factors. This pioneering approach involves immobilizing the MSCs in an extracorporeal device, allowing for doses of therapeutic secreted factors that are unattainable by direct injection. The company received a significant $12.00M Series A investment on April 4th, 2017, which included support from Mass Medical Angels, BIVF, Chiesi Ventures, BioInnovation, MBLVC. Sentien Biotechnologies operates in the biotechnology and health care industries, positioning itself at the forefront of groundbreaking advancements in medical treatment.

Taxonomy: cell therapy, drug delivery systems, MSCs, inflammatory diseases treatment, immune system modulation, clinical-stage company, blood conditioning approach, anti-inflammatory therapy, regenerative medicine, biomedical engineering, extracorporeal devices, biopharmaceuticals, biotech startups

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $12.00M 5
Mass Medical Angels Chiesi Ventures BioInnovation
Mass Medical Angels, Chiesi Ventures +3
04 Apr 2017
Seed Round $1.05M -
05 Aug 2015
Grant Undisclosed -
26 Aug 2014
Grant $1.37M -
25 Apr 2012
Grant $715.00K -
25 Nov 2010

Sentien Biotechnologies, Inc. Alternatives & Competitors

View All Alternatives
Sentien Biotechnologies, Inc. vs
SetPoint Medical
SetPoint Medical United States

Regulating Inflammation - through the nervous system

Venture round
74 employees
Biotechnology, Health Care
Sentien Biotechnologies, Inc. vs
Taiga Biotechnologies
Taiga Biotechnologies United States

Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the power of t...

Seed
1 employees
Biotechnology, Health and Wellness
Sentien Biotechnologies, Inc. vs
Tridek-One
Tridek-One France

We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases

Venture round
12 employees
Biotechnology, Health Care
View all alternatives

FAQ About Sentien Biotechnologies, Inc.

Restoring Balance to the Immune System
Sentien Biotechnologies, Inc. was founded in 2008.
Sentien Biotechnologies, Inc. operates in Biotechnology, Health Care and Health and Wellness. Its work centres on cell therapy, drug delivery systems, MSCs and inflammatory diseases treatment.
Sentien Biotechnologies, Inc. has approximately 5 employees.
Sentien Biotechnologies, Inc. has completed 5 funding rounds, raising a total of $15.13M. The latest funding stage is Series A.
Top alternatives and competitors to Sentien Biotechnologies, Inc. include SetPoint Medical, Taiga Biotechnologies, Tridek-One, Upstream Bio, Cutanos GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sentien Biotechnologies, Inc. and SetPoint Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sentien Biotechnologies, Inc., https://bouncewatch.com/company/sentien-biotechnologies-inc, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes